NCT00683618
Compare the Efficacy of Rosuvastatin to Atorvastatin in High Risk Patients With Hypercholesterolemia
See it on ClinicalTrials.gov ↗414 people
59.4%
40.6%
246 womenmiddle line = equal numbers168 men
- Phase
- PHASE3
- Paid for by
- AstraZeneca
- Finished
- 2009-07
- Health conditions
- Hypercholesterolemia
- Who could join
- Anyone
- Ages
- 18 Years – no maximum
- Average age
- mean 59.5 Years
- Age 65+
- Not reported
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- Asian 100% · American Indian / Alaska Native 0% · Native Hawaiian / Pacific Islander 0% · Black / African American 0% · White 0% · More than one race 0% · Not reported 0%
Women left out
- No heart disease
Women with heart disease, heart rhythm problems or a past heart attack were turned away.
“Unstable or uncontrolled cardiovascular diseases”
Study titles and rules are shown in their original English.